These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8445676)

  • 41. Total synthesis and biological activity of dolastatin 16.
    Casalme LO; Yamauchi A; Sato A; Petitbois JG; Nogata Y; Yoshimura E; Okino T; Umezawa T; Matsuda F
    Org Biomol Chem; 2017 Feb; 15(5):1140-1150. PubMed ID: 28074955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antineoplastic agents 360. Synthesis and cancer cell growth inhibitory studies of dolastatin 15 structural modifications.
    Pettit GR; Flahive EJ; Boyd MR; Bai R; Hamel E; Pettit RK; Schmidt JM
    Anticancer Drug Des; 1998 Jan; 13(1):47-66. PubMed ID: 9474242
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The molecular pharmacology of symplostatin 1: a new antimitotic dolastatin 10 analog.
    Mooberry SL; Leal RM; Tinley TL; Luesch H; Moore RE; Corbett TH
    Int J Cancer; 2003 Apr; 104(4):512-21. PubMed ID: 12584751
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of tubulin polymerization by vitilevuamide, a bicyclic marine peptide, at a site distinct from colchicine, the vinca alkaloids, and dolastatin 10.
    Edler MC; Fernandez AM; Lassota P; Ireland CM; Barrows LR
    Biochem Pharmacol; 2002 Feb; 63(4):707-15. PubMed ID: 11992639
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antineoplastic agents 337. Synthesis of dolastatin 10 structural modifications.
    Pettit GR; Srirangam JK; Barkoczy J; Williams MD; Durkin KP; Boyd MR; Bai R; Hamel E; Schmidt JM; Chapuis JC
    Anticancer Drug Des; 1995 Oct; 10(7):529-44. PubMed ID: 7495477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preclinical analysis of tasidotin HCl in Ewing's sarcoma, rhabdomyosarcoma, synovial sarcoma, and osteosarcoma.
    Garg V; Zhang W; Gidwani P; Kim M; Kolb EA
    Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5446-54. PubMed ID: 17875774
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A new tubulin polymerization inhibitor, auristatin PE, induces tumor regression in a human Waldenstrom's macroglobulinemia xenograft model.
    Mohammad RM; Limvarapuss C; Wall NR; Hamdy N; Beck FW; Pettit GR; Al-Katib A
    Int J Oncol; 1999 Aug; 15(2):367-72. PubMed ID: 10402249
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation of dolastatin 10 from the marine cyanobacterium Symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1.
    Luesch H; Moore RE; Paul VJ; Mooberry SL; Corbett TH
    J Nat Prod; 2001 Jul; 64(7):907-10. PubMed ID: 11473421
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions of the sponge-derived antimitotic tripeptide hemiasterlin with tubulin: comparison with dolastatin 10 and cryptophycin 1.
    Bai R; Durso NA; Sackett DL; Hamel E
    Biochemistry; 1999 Oct; 38(43):14302-10. PubMed ID: 10572005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro pharmacology of cryptophycin 52 (LY355703) in human tumor cell lines.
    Wagner MM; Paul DC; Shih C; Jordan MA; Wilson L; Williams DC
    Cancer Chemother Pharmacol; 1999; 43(2):115-25. PubMed ID: 9923816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synthesis and antiproliferative activity of a cyclic analog of dolastatin 10.
    Poncet J; Hortala L; Busquet M; Guéritte-Voegelein F; Thoret S; Pierré A; Atassi G; Jouin P
    Bioorg Med Chem Lett; 1998 Oct; 8(20):2855-8. PubMed ID: 9873636
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combinatorial strategies by marine cyanobacteria: symplostatin 4, an antimitotic natural dolastatin 10/15 hybrid that synergizes with the coproduced HDAC inhibitor largazole.
    Taori K; Liu Y; Paul VJ; Luesch H
    Chembiochem; 2009 Jul; 10(10):1634-9. PubMed ID: 19514039
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
    Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
    Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preclinical pharmacology of the natural marine product dolastatin 10 (NSC 376128).
    Newman RA; Fuentes A; Covey JM; Benvenuto JA
    Drug Metab Dispos; 1994; 22(3):428-32. PubMed ID: 8070319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fenretinide-induced apoptosis of human head and neck squamous carcinoma cell lines.
    Scher RL; Saito W; Dodge RK; Richtsmeier WJ; Fine RL
    Otolaryngol Head Neck Surg; 1998 Apr; 118(4):464-71. PubMed ID: 9560096
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dolastatin-10 in metastatic melanoma: a phase II and pharmokinetic trial of the California Cancer Consortium.
    Margolin K; Longmate J; Synold TW; Gandara DR; Weber J; Gonzalez R; Johansen MJ; Newman R; Baratta T; Doroshow JH
    Invest New Drugs; 2001; 19(4):335-40. PubMed ID: 11561695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of cIAP-1 by novel antitubulin agents when combined with bryostatin 1 results in increased apoptosis in the human early pre-B acute lymphoblastic leukemia cell line Reh.
    Wall NR; Mohammad RM; Nabha SM; Pettit GR; Al-Katib AM
    Biochem Biophys Res Commun; 1999 Dec; 266(1):76-80. PubMed ID: 10581168
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Natural products which interact with tubulin in the vinca domain: maytansine, rhizoxin, phomopsin A, dolastatins 10 and 15 and halichondrin B.
    Hamel E
    Pharmacol Ther; 1992; 55(1):31-51. PubMed ID: 1287674
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of antineoplastic agents by MTT assay: partial underestimation of antiproliferative properties.
    Sobottka SB; Berger MR
    Cancer Chemother Pharmacol; 1992; 30(5):385-93. PubMed ID: 1505077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of dolastatin 10 with bovine brain tubulin.
    Ludueña RF; Roach MC; Prasad V; Pettit GR
    Biochem Pharmacol; 1992 Feb; 43(3):539-43. PubMed ID: 1540211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.